Answers are grounded in this paper and cite their sources.
Introduction Lipodystrophy syndromes (LD) are rare disorders characterised by the absence and/or dysfunction of white adipose tissue. Defects in adipose tissue function impair its capacity to optimally buffer surplus energy intake and absolute, or relative, leptin deficiency exacerbates the mismatch between energy intake and storage capacity. Recombinant leptin therapy reduces food intake and substantially improves metabolic parameters in patients with generalised lipodystrophy but is less effective in patients with PLD. Here we demonstrate the metabolic impact of reduced calorie intake in people with PLD. Methods This prospective study involved a 12-week low-energy (800-1000kcal/day) diet intervention. Thereafter, food was re-introduced, and participants followed for 1 year. We recruited people with PLD and diabetes. The primary endpoint was a reduction in HbA1c at 12 weeks. Secondary endpoints included reductions in HbA1c at 1 year and reductions in fasting glucose, serum triglycerides, hepatic fat and glucose-lowering medication use at 12 weeks and 12 months. Results Six participants (5 FPLD1 and 1 FPLD3) completed the study. Body weight fell from 89.0kg (IQR 76.5 to 90.8) to 74.7kg (IQR 61.0 to 75.7, p=0.03) and HbA1c was reduced from 66.5 mmol/mol (IQR 59 to 69.5) to 41.5mmol/mol (IQR 34.5 to 48.5, p=0.03) by week 12. Food reintroduction, typically led to weight regain but this can be effectively mitigated by use of GIP/GLP1 RAs. Conclusion Reducing calorie intake alone results in marked metabolic improvement in people with PLD but is difficult to sustain.
No takes yet. Share an insight, caveat, or question.
Mandour et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: